Genmab — September 2019
-
Bliv længe oppe i aften, Solsen. Esmo offentliggør abs kl 5 min over midnat. Hvis dr5 er med som lb, offentliggøres det først når den skal på. https://www.esmo.org/Conferences/ESMO-Congress-2019/Abstracts
-
https://www.bebpa.org/2019-eu-bioassay-abstracts/ Lidt nede i
omtales et indlæg om Gen1029 -
Genmab Announces U.S. FDA Approval of DARZALEX
(daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple Myeloma
September 26, 2019 at 5:43 PM CEST
Company AnnouncementDARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, thalidomide (an immunomodulatory agent) and dexamethasone as treatment for patients newly diagnosed with multiple myeloma who are eligible for autologous stem cell transplant
Approval based on Phase III CASSIOPEI -
-
God nyhed...igen...
-
well , then let me repeat this also
Prof. Philippe Moreau: "I think that when we are going to use quadruplet combination including CD38 antibodies plus SCT, we are going to #cure some young patients" in this interview on #daratumumab + VTdhttps://www.targetedonc.com/news/daratumumab-improves-responses-pfs-in-newly-diagnosed-transplanteligible-myeloma -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind